Tilray Inc. (TLRY)

44.25
0.16 0.36
NASDAQ : Health Technology
Prev Close 44.41
Open 44.37
Day Low/High 44.06 / 45.48
52 Wk Low/High 20.10 / 300.00
Volume 969.47K
Avg Volume 1.56M
Exchange NASDAQ
Shares Outstanding 80.56M
Market Cap 4.30B
EPS -0.80
P/E Ratio N/A
Div & Yield N.A. (N.A)
What If Canopy Growth Is Getting Too High?

What If Canopy Growth Is Getting Too High?

This is simply a short-term thesis that the cannabis rally will cool this week.

Low Volume and Seasonality Is No Reason to Fight This Stock Market Uptrend

Low Volume and Seasonality Is No Reason to Fight This Stock Market Uptrend

Seasonality hasn't mattered in a number or years so why should light volume new highs be an issue?

Tilray Offers Test of Transitioning to Recreational Cannabis Use in Canada

Tilray Offers Test of Transitioning to Recreational Cannabis Use in Canada

The Nasdaq-listed provider of medical marijuana will compete with other firms as Canada opens itself to general adult use of marijuana this fall.

Closing Bell: LIVE MARKETS BLOG

Closing Bell: LIVE MARKETS BLOG

The company said that it has closed a $427 million funding round.

Why Pay a Premium for Estee Lauder?

Why Pay a Premium for Estee Lauder?

EL's stock is up despite a guidance cut.

Tilray Rated New Buy at Roth Capital

Cannabis Firm Tilray's Successful IPO Has Other Firms High on Going Public

Cannabis Firm Tilray's Successful IPO Has Other Firms High on Going Public

Expect several more firms to list on stock exchanges this year.

Cannabis Specialist Acreage Eyes National Footprint as It Raises $119 Million

Cannabis Specialist Acreage Eyes National Footprint as It Raises $119 Million

Acreage Holdings plans to publicly list common stock through a reverse merger on the Canadian Securities Exchange in the fall.

Podcast: What Does the Cannabis Industry Have in Common with the Dot-Com?

Podcast: What Does the Cannabis Industry Have in Common with the Dot-Com?

Does the smoking cannabis industry share more than a few things in common with the Dot-com in the 1990s. Check out this podcast from the Real Money team.

Tilray CEO: Surging Cannabis Industry Is a Threat to Food and Drug Players

Tilray CEO: Surging Cannabis Industry Is a Threat to Food and Drug Players

Tilray is full steam ahead in taking on some established players in the food and drug industry. CEO Brendan Kennedy discusses the company's efforts to grow.

How This Former VC Player Became CEO of $2 Billion Cannabis Company Tilray

How This Former VC Player Became CEO of $2 Billion Cannabis Company Tilray

Cannabis company Tilray is fresh off a smoking hot IPO this week. TheStreet talks with Tilray's CEO Brendan Kennedy about how he came to the cannabis industry.

Cannabis Firm MPX Takes Aim at N.J., California Markets

Cannabis Firm MPX Takes Aim at N.J., California Markets

MPX is expanding its footprint in several U.S. states.

Tilray CEO: IPO Marks the Mainstreaming of Cannabis Industry

Tilray CEO: IPO Marks the Mainstreaming of Cannabis Industry

Medicinal cannabis company Tilray saw a robust response to its IPO on the Nasdaq Thursday. TheStreet talks with Tilray's CEO Brendan Kennedy about the company's prospects.